Interestingly, FMT improves cognitive function by lowering amyloid-β accumulation and upregulating synaptic marker (PSD-95, synapsin-1) expression in Alzheimer’s disease. Here, SYN1 is linked to early-onset autosomal dominant Alzheimer disease.